Record Details

α-Glucan pathway as a novel Mtb drug target: structural insights and cues for polypharmcological targeting of GlgB and GlgE.

DIR@IMTECH: CSIR-Institute of Microbial Technology

View Archive Info
 
 
Field Value
 
Title α-Glucan pathway as a novel Mtb drug target: structural insights and cues for polypharmcological targeting of GlgB and GlgE.
 
Creator Agrawal, Pushpa
Gupta, Pawan
Swaminathan, Kunchithapadam
Parkesh, Raman
 
Description Tuberculosis continues to be a deadly infectious disease, mainly due to the existence of persistent bacterial populations that survive drug treatment and obstruct complete eradication of infection. The enzymes GlgE and GlgB, which are involved in the glycan pathway, have recently been identified as promising drug targets for combating persistent bacillus strains. In the glycan pathway, enzymes GlgE, GlgA, and Tre-xyz produce linear α-glucans, which are then converted to essential branched α-glucan by GlgB. This α-glucan is a vital cell-wall and storage polysaccharide, critical for Mtb virulence and persistence. We highlight recent insights into the significance of both GlgE and GlgB in the glycan pathway and also discuss drug strategies for tuberculosis such as polypharmcological targeting of GlgB and GlgE. Small molecule-based modulation of GlgB and GlgE to boost the design and development of novel and improved drugs for more selective and efficient targeting of tuberculosis are also discussed.
 
Publisher Schiphol, The Netherlands : Bentham Science Publishers,
 
Date 2014
 
Type Article
PeerReviewed
 
Relation http://www.eurekaselect.com/124187/article
http://crdd.osdd.net/open/1569/
 
Identifier Agrawal, Pushpa and Gupta, Pawan and Swaminathan, Kunchithapadam and Parkesh, Raman (2014) α-Glucan pathway as a novel Mtb drug target: structural insights and cues for polypharmcological targeting of GlgB and GlgE. Current medicinal chemistry, 21 (35). pp. 4074-84. ISSN 1875-533X